Illinois General Assembly - Bill Status for HB5405
Illinois General Assembly

  Bills & Resolutions  
  Compiled Statutes  
  Public Acts  
  Legislative Reports  
  IL Constitution  
  Legislative Guide  
  Legislative Glossary  

 Search By Number
 (example: HB0001)
Search Tips

Search By Keyword

 Bill Status of HB5405  103rd General Assembly


Short Description:  DIVERSITY IN CLINICAL TRIALS

House Sponsors
Rep. Marcus C. Evans, Jr. - Eva-Dina Delgado, Yolonda Morris, Theresa Mah and Camille Y. Lilly

Last Action
DateChamber Action
  4/4/2024HousePlaced on Calendar 2nd Reading - Short Debate

Statutes Amended In Order of Appearance
20 ILCS 2310/2310-730 new


Synopsis As Introduced
Amends the Department of Public Health Powers and Duties Law of the Civil Administrative Code of Illinois. Sets forth requirements for any State entity or hospital that receives funding from the National Institutes of Health to conduct clinical trials of drugs or medical devices. Provides that the Department of Public Health, in consultation with relevant research organizations, shall analyze and provide recommendations on: (i) the demographic groups and populations that are currently represented and underrepresented in clinical trials in the State, including representation of groups based on their geographic location; (ii) the barriers that prevent persons who are members of underrepresented demographic groups from participating in clinical trials in the State, including barriers related to transportation; and (iii) approaches for how clinical trials can successfully partner with others to provide outreach to underrepresented communities. Provides that the Department shall report to the General Assembly on the results of the study by July 1, 2025. Sets forth definitions of underrepresented community and underrepresented demographic group. Provides that the Department shall review guidance published by the United States Food and Drug Administration and use existing infrastructure to encourage participation in clinical trials of drugs and medical devices by persons who are members of underrepresented demographic groups. Authorizes the Department to apply for any grants related to the encouragement of underrepresented demographic groups related to the United Food and Drug Administration's guidance.

Actions 
DateChamber Action
  2/9/2024HouseFiled with the Clerk by Rep. Marcus C. Evans, Jr.
  2/9/2024HouseFirst Reading
  2/9/2024HouseReferred to Rules Committee
  3/5/2024HouseAssigned to Public Health Committee
  4/4/2024HouseDo Pass / Short Debate Public Health Committee; 009-000-000
  4/4/2024HouseAdded Co-Sponsor Rep. Yolonda Morris
  4/4/2024HouseAdded Co-Sponsor Rep. Theresa Mah
  4/4/2024HousePlaced on Calendar 2nd Reading - Short Debate
  4/4/2024HouseHouse Floor Amendment No. 1 Filed with Clerk by Rep. Marcus C. Evans, Jr.
  4/4/2024HouseHouse Floor Amendment No. 1 Referred to Rules Committee
  4/10/2024HouseAdded Co-Sponsor Rep. Camille Y. Lilly
  4/12/2024HouseAdded Chief Co-Sponsor Rep. Eva-Dina Delgado

Back To Top